Gaush Meditech Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind

Reuters

2025/09/30

<a href="https://laohu8.com/S/02407">Gaush Meditech</a> Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind

Gaush Meditech Ltd. has announced the renewal of its exclusive distribution agreement with Schwind eye-tech-solutions GmbH, a Germany-based manufacturer specializing in refractive surgery devices. Under the renewed agreement, Gaush Meditech's subsidiary, Mingwang Medical Ltd., will continue to be responsible for the sales, promotion, and related services of Schwind's products in Mainland China, Hong Kong, and Macau. The collaboration between the two companies began in 2009 and has now been extended to further strengthen Gaush Meditech's position in the Chinese refractive surgery device market. Schwind's portfolio includes the ATOS personalized navigation femtosecond laser and the AMARIS excimer laser series, which are widely used in clinical practices globally. The company stated that this renewed partnership is expected to bring additional opportunities for growth. Shareholders and potential investors have been advised to exercise caution when dealing in the company's shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gaush Meditech Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2571342017"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571342017\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571342017?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 20:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571342017","market":"fut","top_or_hot":-1,"title":"Gaush Meditech Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/02407\">Gaush Meditech</a> Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Gaush Meditech Ltd. has announced the renewal of its exclusive distribution agreement with Schwind eye-tech-solutions GmbH, a Germany-based manufacturer specializing in refractive surgery devices. Under the renewed agreement, Gaush Meditech's subsidiary, Mingwang Medical Ltd., will continue to be responsible for the sales, promotion, and related services of Schwind's products in Mainland China, Hong Kong, and Macau. The collaboration between the two companies began in 2009 and has now been extended to further strengthen Gaush Meditech's position in the Chinese refractive surgery device market. Schwind's portfolio includes the ATOS personalized navigation femtosecond laser and the AMARIS excimer laser series, which are widely used in clinical practices globally. The company stated that this renewed partnership is expected to bring additional opportunities for growth. Shareholders and potential investors have been advised to exercise caution when dealing in the company's shares.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gaush Meditech Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gaush Meditech Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGaush Meditech Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-30 20:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/02407\">Gaush Meditech</a> Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Gaush Meditech Ltd. has announced the renewal of its exclusive distribution agreement with Schwind eye-tech-solutions GmbH, a Germany-based manufacturer specializing in refractive surgery devices. Under the renewed agreement, Gaush Meditech's subsidiary, Mingwang Medical Ltd., will continue to be responsible for the sales, promotion, and related services of Schwind's products in Mainland China, Hong Kong, and Macau. The collaboration between the two companies began in 2009 and has now been extended to further strengthen Gaush Meditech's position in the Chinese refractive surgery device market. Schwind's portfolio includes the ATOS personalized navigation femtosecond laser and the AMARIS excimer laser series, which are widely used in clinical practices globally. The company stated that this renewed partnership is expected to bring additional opportunities for growth. Shareholders and potential investors have been advised to exercise caution when dealing in the company's shares.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gaush Meditech Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDLbqx21:1","article_id":"2571342017","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571342017","pubTimestamp":1759234306,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Gaush Meditech Ltd. has announced the renewal of its exclusive distribution agreement with Schwind eye-tech-solutions GmbH, a Germany-based manufacturer specializing in refractive surgery devices. Under the renewed agreement, Gaush Meditech's subsidiary, Mingwang Medical Ltd., will continue to be responsible for the sales, promotion, and related services of Schwind's products in Mainland China, Hong Kong, and Macau. The collaboration between the two companies began in 2009 and has now been extended to further strengthen Gaush Meditech's position in the Chinese refractive surgery device market. Schwind's portfolio includes the ATOS personalized navigation femtosecond laser and the AMARIS excimer laser series, which are widely used in clinical practices globally. The company stated that this renewed partnership is expected to bring additional opportunities for growth. Shareholders and potential investors have been advised to exercise caution when dealing in the company's shares.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1100":"医疗保健设备","02407":"高视医疗"},"translate_title":"Gaush Meditech Ltd.宣布与德国Schwind续签独家经销协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02407":0.9},"content_text":"Gaush Meditech Ltd. Announces Renewal of Exclusive Distribution Agreement with Germany-Based Schwind\n    \n\n        Gaush Meditech Ltd. has announced the renewal of its exclusive distribution agreement with Schwind eye-tech-solutions GmbH, a Germany-based manufacturer specializing in refractive surgery devices. Under the renewed agreement, Gaush Meditech's subsidiary, Mingwang Medical Ltd., will continue to be responsible for the sales, promotion, and related services of Schwind's products in Mainland China, Hong Kong, and Macau. The collaboration between the two companies began in 2009 and has now been extended to further strengthen Gaush Meditech's position in the Chinese refractive surgery device market. Schwind's portfolio includes the ATOS personalized navigation femtosecond laser and the AMARIS excimer laser series, which are widely used in clinical practices globally. The company stated that this renewed partnership is expected to bring additional opportunities for growth. Shareholders and potential investors have been advised to exercise caution when dealing in the company's shares.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gaush Meditech Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}